Promoting Immunotherapy Efficacy With Low-Dose Liver RT
for
Low-Dose Liver Radiation (LD-LRT), Non Small Cell Lung Cancer,
Location: Cincinnati OH
Sponsor: Jordan Kharofa
Sex: All
Age: 18+
Code: NCT07225036
Recruiting
Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery
for
ACL Injury, Hip Injuries
Location: Cleveland OH
Sponsor: University Hospitals Cleveland Medical Center
Sex: All
Age: 14 - 30
Code: NCT05488054
Recruiting
Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)
for
Clear Cell Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07187778
Phase2, Recruiting
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study
for
Post Operative Pain, Spinal Surgery
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18 - 70+
Code: NCT07222072
Recruiting
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
for
Extensive-stage Small-cell Lung Cancer
Location: Burlington MA, White Plains NY, New York NY,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06712355
Phase3, Recruiting
Food and Circadian Timing
for
Diet, High-Fat, Circadian Rhythm
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 18 - 40
Code: NCT04743271
Recruiting
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
for
Non-Small Cell Lung Cancer
Location: Boston MA, Mineola NY, New York NY, Philadelphia PA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07100080
Phase2, Phase3, Recruiting
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
for
Renal Cell Carcinoma, Non Small Cell Lung Cancer, Melanoma,